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Summary
The complete repair of periodontal structures remains
an exciting challenge that prompts researchers to devel-
op new treatments to restore the periodontium. Recent
research has suggested strontium ion to be an attractive
candidate to improve osteogenic activity. 
In this study, we have isolated a clonal finite cell line de-
rived from human periodontal ligament (PDL) in order to
assess whether and in which way different doses of Sr-
Cl2 (from 0.5 to 500 μg/ml) can influence both the prolif-
eration and the mineralization process, for future appli-
cation in oral diseases. 
PDL cells were cloned by dilution plating technique and
characterized by FACS. Cell proliferation analysis and
mineralization were performed by [3H]-thymidine incor-
poration and spectrofluorometric assay.
Results have evidenced that the higher SrCl2 concentra-
tions tested, from 25 to 500 μg/ml, have increased the
proliferation activity after only 24 h of treatment. Inter-
estingly, the same higher concentrations have de-
creased the mineralization, which was conversely in-
creased by the lower ones, from 0.5 to 10 μg/ml.
Our findings suggest the possible use of SrCl2 in appro-
priate delivery systems that release, at different time
points, the specific dose, depending on the biological re-
sponse that we want to induce on periodontal ligament
stem cells, providing a more efficient periodontal regen-
eration.
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Introduction
The periodontal ligament (PDL) is a soft connective tissue
embedded between the cementum, covering the root of the
tooth, and the inner wall of the alveolar bone socket (1). The
PDL provides anchorage and support to the functional tooth,
dispersing the mechanical forces associated with mastication
(2).
Periodontitis, a chronic inflammatory disease, is a common
and widespread condition that causes the destruction of the
tooth-supporting tissues including the PDL, the alveolar bone
and the root cementum. This pathology affects more than
60% of adults with a 10% of aggressive forms, which are
able to produce a quick progression of the tissue damage
(1); in fact, if left untreated, periodontitis will result in pro-
gressive periodontal attachment and bone loss that may lead
to premature tooth loss, representing a harmful implication
on the individual’s quality of life and a substantial public
health burden worldwide (3). It is therefore evident that the
regeneration of a healthy periodontium, that has been de-
stroyed by periodontal disease, is the major goal of peri-
odontal therapy. 
Current conventional techniques for the treatment of peri-
odontal disease, which aim to decrease microbial levels and
modify the local environment to reduce inflammation, have
shown a limited potential for complete periodontal regenera-
tion. The topical direction to enhance periodontal tissue re-
construction and its biomechanical integration is represented
by the use of mesenchymal stem cells for the development
of scaffolding matrices in combination with specific bioactive
molecules that can drive and promote the complete process
of regeneration.
Mesenchymal stem cells have been isolated from teeth in-
cluding dental pulp, apical papilla, and dental follicle (4). Of
particular interest are the cell populations derived from PDL,
as the presence of multiple cell types (cementoblasts, os-
teoblasts, fibroblasts) within PDL suggests that this tissue
contains progenitors, which maintain tissue homeostasis and
regeneration of the periodontal tissues (5). Earlier evidence
has shown that PDL contains cell populations which have
the characteristics of postnatal stem cells, are self-renew-
able and possess the ability to give rise to a range of differ-
ent phenotypes (cementoblasts, adipocytes and chondro-
cytes) (1, 6, 7). Moreover, in various animal models, implant-
ed PDL-derived mesenchymal stem cells (PDLSCs) have
shown the capacity to generate a cementum/PDL-like struc-
ture similar to the native periodontal complex (1). Based on
these findings, PDLSCs are now considered a more appro-
priate cell type for developing novel tissue strategies for re-
generating dental tissue.
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Strontium, Sr, an alkaline earth metal, is an important trace
element in the human body. It has interesting properties and
is chemically similar to calcium, thus, it can substitute calci-
um in the bone matrix relatively easily. It has been found to
induce osteoblast activity by stimulating bone formation and
reducing bone resorption (8). Moreover, in several studies, it
has been reported to stimulate osteogenic differentiation and
proliferation in mesenchymal stem cells and osteoblasts (9,
10).
However, to our best knowledge, there are few studies re-
garding the effects of strontium on the proliferation and min-
eralization processes of mesenchymal stem cells isolated
from human PDL (11, 12). In particular, there are no articles
which simultaneously analyze both of the above mentioned
processes in human PDLSCs treated with the same SrCl2
concentrations. For this reason, the aim of our study was to
evaluate and define the in vitro effects of a wide range of Sr-
Cl2 concentrations, from 0.5 to 500 μg/ml, in order to bring
additional and more specific evidences to support the possi-
ble use of SrCl2 in combination with PDLSCs, helping to im-
prove the outcome of cellular therapy for periodontal regen-
eration.
Materials and methods
Isolation of primary human PDL cells and cultures
A normal impacted third molar was extracted from a patient
(male, age 23) after orthodontic treatment, and processed
within 3 hours from the extraction. The procedure was ap-
proved by the Local Ethics Committee AOU Careggi (Rif. n.
140-12) and was performed after obtaining signed informed
consent from a patient, in accordance with the ethical stan-
dard stated in the Declaration of Helsinki. Tissue from the
PDL was gently excised with a scalpel from the middle third
of the freshly extracted tooth. The PDL tissue was then en-
zymatically digested with 3 mg/ml collagenase type I (Sigma-
Aldrich, Saint Luis, MO, USA) for 1 hour at 37°C. Single-cell
suspensions were obtained with a 70 μm cell strainer (Merck
Millipore, Darmstad, Germany). To separate cells expected
to be stem cells, we allowed the suspension to attach and
proliferate, until confluence, to 100 mm dishes (Falcon,
Madison, SD, USA) in growth medium (GM) composed by
Ham’s F12 Coon’s medium supplemented with 10% fetal
bovine serum (FBS), (Sigma-Aldrich, Saint Luis, MO, USA),
100 U/ml penicillin and 100 μg/ml streptomycin at 37°C in
5% carbon dioxide in humidified atmosphere. 
Immunomagnetic isolation of CD44+ PDL cells
The isolation of putative PDLSCs was made through im-
munomagnetic isolation by MicroBeads (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany). Single-cell suspen-
sion of 106 PDLSCs was incubated with 20 μl of CD44 Mi-
croBeads for 15 minutes on ice. The cells were then washed
with phosphate buffered saline containing 1% bovine serum
albumin and centrifuged at 300 x g for 10 minutes. Beads
positive cells were isolated with a magnetic particle concen-
trator according to the manufacturer’s instruction, and left
proliferating in 100 mm-dishes in GM. The medium was re-
freshed twice a week and the cells were used for subcultur-
ing or cryopreservation upon reaching 70 - 80% confluence.
Isolated cells were expanded and used at passage 2 for cell
cloning. 
Cloning of CD44+ PDL cells
CD44+ PDL cells at the second passage were used for cell
cloning. Cells in an active phase of growth were cloned by
the dilution plating technique. Cells were detached with
trypsin 1:250 (BD, Franklin Lakes, NJ, USA) 0.4 mg/ml in
Dulbecco’s Phosphate Buffered Saline (DPBS) without Ca2+
and Mg2+, with EDTA 0.2 mg/ml and with glucose 1 mg/ml.
The cells were then resuspended in Coon’s medium with
20% FCS. The cell suspension was diluted to a concentra-
tion of 10 cells/ml in the following cloning medium: Coon’s
medium with 20% FCS supplemented with 25% conditioned
medium prepared from human fetal fibroblast culture. The
cell suspension was maintained in agitation, and 0.1 ml/well
was rapidly distributed in a 96-well half area tissue culture
plate. Each well was carefully observed during the following
days and the wells containing only one cell were scored. The
cloning culture was incubated at 37°C in humidified air with
5% CO2. When the colonies reached 500-1000 cells, they
were detached, collected, transferred in 24 well plates and
subsequently expanded in 60 mm and 100 mm dishes.
Flow cytometry analysis
Stemness surface markers of PDLSCs finite clonal line were
evaluated by flow cytometry with a CyFlowSpace cytometer
(Sysmex Partec GmbH, Görlitz, Germania), equipped with
FlowMax software. The antibodies used were directed
against the following antigens (the tags are given in paren-
theses): CD44 (PE/Cy7), CD105 (FITC), CD90 (APC), CD45
(PerCP), CD34 (PE) (all Abcam, Cambridge, UK), CD133
(PE), CD271 (FITC) (Miltenyi Biotec GmbH, Bergisch Glad-
bach, Germany) and CD117 (FITC) (Bioss Antibodies). Each
antibody was diluted according to manufacturer’s instruction.
Briefly, 1 x 105 cells were labeled with antibodies in PBS with
1% bovine serum albumin (BSA) for 20 min RT in the dark,
then washed once and promptly analyzed.
Soft agar assay for neoplastic transformation
Neoplastic transformed cells form colonies that grow pro-
gressively in soft agar. A 35 mm dish was coated with 1%
agar prepared in culture medium and maintained in liquid
state at 45°C. The dish was immediately cooled. Cells in
growth phase were detached, suspended in medium, diluted
to double the required final concentration, and maintained at
37°C. Agar (0.68%) was prepared in medium and maintained
at 45°C. The cell suspension was mixed with an equal vol-
ume of 0.68% agar, distributed into the agar coated dish to
obtain a final concentration of 2.5 x 103 cells/dish, and imme-
diately cooled. The cells were cultured at 37°C in humidified
air with 5% CO2 for 3-4 weeks until the formation and growth
of the colonies. The colonies that formed in each dish were
observed and counted in phase contrast microscopy. Sus-
pended clusters greater than 0.2 mm diameter are consid-
ered as colonies.
Colony forming unit assay
To test colony forming unit (CFU) capability of the PDLSCs,
single-cell suspension of 102 cells was seeded into 100-mm
diameter culture dishes and cultured for 2 weeks in GM. Af-
ter fixation for 20 minutes with 4% p-formaldehyde, and ex-
tensive washes with ultrapure water, cells were stained with
0.1% (w/v) toluidine blue to assess colony formation efficien-
cy. Fifty or more cells clustered together were considered a
colony.
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Multiple differentiation potential of PDLSCs 
Multipotency evaluation was assessed inducing PDLSCs to-
ward both the osteogenic and adipogenic phenotypes, as de-
scribed below. 
Osteogenic differentiation: PDLSCs were plated on tissue
culture dishes at a cell density of 1 x 104 cells/cm2 in GM
and grown to 70 - 80% confluence. Afterwards, the medium
was changed to osteogenic medium (OM): Ham’s F12
Coon’s modification medium supplemented with 10% FBS,
100 IU/ml penicillin, 100 μg/ml streptomycin, 10 nM dexam-
ethasone, 0.2 mM sodium L-ascorbyl-2-phosphate, and 10
mM β-glycerol phosphate. In order to visualize calcium min-
eral deposits in epifluorescence microscopy, fluorophore cal-
cein 1 μg/ml was added to the OM during the entire study
period. The medium was refreshed twice a week. The ex-
pression of the osteoblastic phenotype was evaluated until
21 days from induction by monitoring ALP activity and miner-
alization by cytochemical staining. For ALP staining, the cells
were washed with DPBS (twice), stained with a specific dye
mixture: 5 mg naphthol-AS-MX phosphate sodium salt, previ-
ously dissolved in 1 ml dimethyl sulfoxide, 40 mg Fast Red
Violet LB, dissolved in 49 ml Tris-HCl Buffer 280 mM pH 9.0
for 30 minutes at 37°C. The cells were then washed with
DPBS (twice), fixed in 4% p-formaldehyde for 15 minutes,
and washed with ultrapure water (three times). ALP+ cells,
stained in red, and nuclei, counterstained in blue with May-
er’s acid hemalum, were observed in brightfield microscopy.
For mineralization staining, the cells were washed with
DPBS (two times), fixed in 4% p-formaldehyde for 15 min-
utes, and washed with ultrapure water (three times). Calcium
mineral deposits, stained with calcein, and nuclei, counter-
stained with 10-5M propidium iodide, were visualized in epi-
fluorescence microscopy.
Adipogenic differentiation: PDLSCs were cultured with a spe-
cific adipogenic medium (AM): Ham’s F12 Coon’s modifica-
tion medium supplemented with 10% FBS, 100 IU/ml peni-
cillin, 100 μg/ml streptomycin and 1 μM dexamethasone, 1
μM bovine insulin, 0.5 mM isobutylmethylxanthine (IBMX).
The medium was refreshed twice a week. The expression of
the adipogenic phenotype was evaluated on cells cultured in
AM or GM for 21 days by Oil Red O staining. Cultures were
fixed directly with fresh Oil Red O in alcoholic solution for on-
ly 3 minutes, to avoid the rupture of the lipid droplets, and
immediately observed in brightfield microscopy for photo ac-
quisition.
Immunocytochemistry
PDLSCs were seeded into 24-well plates (1 x 104 cells/well)
and cultured for 24 hours in GM. Then, cells were fixed for
10 minutes with 4% p-formaldehyde and permeabilized for
10 minutes with 0.2% triton X 100 at RT. Afterwards, cells
were treated for another 30 minutes at 37°C with RNAse in
2% bovine serum albumin (BSA) in order to degrade RNA
and block non-specific sites. Then samples were incubated
with primary antibody for CD44 (Abcam, Cambridge, UK) in
PBS at 4°C, overnight. After extensive washes with PBS,
goat anti-mouse IgG (H+L) SuperClonal secondary antibody,
Alexa Fluor 488 conjugate (Thermo Scientific, Waltham,
MA, USA) was incubated for 1 hour at room temperature in
the dark. Subsequently, nuclei were counterstained with 
10-5M propidium iodide. Samples were then washed with
PBS for observation in laser scanning confocal microscopy
(LSCM), using a LSM 510 Meta microscope (ZEISS, Jena,
Germany). 
Treatment with SrCl2 concentrations
Different concentrations of SrCl2•6H2O (Mr 266.6, Sigma-
Aldrich, Saint Luis, MO, USA) were used in the experiments
in order to evaluate the effects of the bioactive ion on
PDLSCs proliferation and osteogenic differentiation. All the
experiments were performed using SrCl2 concentrations from
0.5 to 500 μg/ml added to the media.
Cell proliferation analysis
Incorporation of [3H]-thymidine (PerkinElmer, Waltham, MA,
USA) was performed using semi-confluent PDLSCs in 24
well plates, starved for 48 hours in Ham’s F12 Coon’s modifi-
cation medium supplemented with 0.1% FBS and stimulated
with or without different concentrations of SrCl2 for 24 hours.
After 7 hours of incubation with the addition of 1 μCi of [3H]-
thymidine / 500 μl / well, cells were harvested for analysis.
[3H]-thymidine incorporation was determined using the
LS6500 scintillation counter (Beckman Coulter, Miami, FL,
USA) and radioactivity was  expressed as disintegration per
minute (DMP) / well. 
Calcium content assay
Confluent PDLSCs in 24 well plates were induced to mineral-
ize with several concentrations of SrCl2 in the presence of
fluorophore calcein (1 μg/ml), at different experimental times
(To, 7, 14, 21, 28 days). The multiwell plate was fixed with
4% p-formaldehyde for 10 minutes. After washes in DPBS,
each well was incubated overnight with 1 ml of 50 mM
NaEDTA at RT. The contents of each well were then trans-
ferred into a cuvette and the relative fluorescence measured
by spectrofluorometer LS55 (PerkinElmer, Waltham, MA,
USA) at 494 λ (excitation) and 517 λ (emission), and ex-
pressed in ng calcium deposits/ng DNA, using a standard
curve of hydroxyapatite 25 ng/ml – 2.5 μg/ml solubilized in
NaEDTA. 
Statistical analysis 
Statistical analysis was performed using the Kruskal-Wallis
Test with calculation of least significant difference, compar-
ing the values obtained in presence of different SrCl2 con-
centrations with respect to the control without stimuli. A p-
value of less than 0.05 was considered significant.
Results
Isolation and characterization of PDLSCs
The plastic-adherent cell population derived from human pe-
riodontal ligament, called PDL5, was separated by immuno-
magnetic isolation using CD44 MicroBeads, to identify puta-
tive stem cells. Selected cells were expanded in 100-mm cul-
ture dishes. CD44+ PDLSCs were cloned at passage 2. Nine
clones were obtained and, among them, clone PDL5-F3 was
randomly selected for subsequent characterization. 
The PDL5-F3 cell line showed an elongated and fusiform, fi-
broblast-like shape, with a number of flattened cytoplasmic
extensions (Figure 1 a). Immunocytochemical staining of
CD44, observed in LSCM, has allowed the expression of the
specific stemness marker on the PDL5-F3 cell surface to be
assessed. As expected, it is clearly evidenced how the CD44
protein is presented over the membrane in the 100% of
PDL5-F3 cells (Figure 1 b). 
The ability of these cells to form adherent clonogenic cell
clusters of fibroblast-like cells, with a typical fibroblastic spin-
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dle shape, was shown by the formation of 27 ± 5 single
colonies, generated from 102 single cells cultured at low den-
sity for 2 weeks, with a cloning efficiency of 27 ±  5% (Figure
1 c). On the contrary, the PDL5-F3 line did not show growth
in soft agar after 4 weeks in culture, demonstrating no malig-
nant transformation in cells (Figure 1 d). 
In order to better characterize the PDL5-F3 line, cells were
analyzed by flow cytometry. The phenotype analysis has re-
vealed that PDL5-F3 cells expressed surface markers CD44,
CD90, CD105, commonly used to identify mesenchymal
stem cells, with a very close percentage to 100. In contrast,
the hematopoietic lineage marker CD45 was negative (Fig-
ure 2). Moreover, to further confirm that the cell line, used in
the experiments, is not malignant, we assessed the principal
tumor cell surface markers. The negative results, obtained
for CD133, CD117, CD34 and CD271, together with the soft
agar assay previously shown, were an additional proof that
our cell line was not malignant (Figure 2).
Multipotentiality of PDLSCs 
The multipotentiality of PDLSC cloned was verified by the in-
duction toward the osteogenic and adipogenic phenotypes,
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Figure 1 - Representative image from phase contrast microscopy of the PDL5-F3 clonal cell line grown on plastic (a); observation in
LSC microscopy of CD44 marker (conventional green color) on PDL5-F3 and nuclei counterstained with propidium iodide (conventional
red color), objective 20x (b); representative photo of CFU generated by PDL5-F3 cells (c); representative image from phase contrast
microscopy of the PDL5-F3 cells grown in soft agar, objective 10x (d).
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using appropriate medium described in the ‘Materials and
methods’ section.
Osteogenic induction of the PDL5-F3 line was assessed with
OM up to 21 days and observed during the entire period of
study, monitoring the ALP expression and the production of
mineralized calcium deposits. 
Cytochemical staining, performed at different time points (T0,
4, 7, 14  days), has revealed an increase in ALP activity with
respect to the control incubated in GM, (T0), as shown by
brightfield microscopic images (Figure 3 a-d), highlighting
the activation of the early biochemical marker of the differen-
tiation process after only 4 days of induction. Subsequently,
the ALP activity of PDL5-F3 cells underwent a decrease after
14 days of induction. Control cells grown in GM for the same
time did not show any ALP+ cells.
In order to evaluate the effective deposition of an osteoid
matrix by PDL5-F3 clonal cell line, cells were analyzed at dif-
ferent time points of osteogenic induction (T0, 7, 14, 21
days). The osteoblast activity of the cell line was evidenced
by an increase of mineralized calcium nodules deposition,
adding the fluorophore calcein in OM, yielding a great depo-
sition 3 weeks after induction. Epifluorescence microscopic
observations have shown calcein uptake starting from 14
days of induction (Figure 3e-h). In contrast, control cells
grown in GM for the same time did not show any deposition
of calcium deposits.
Adipogenic differentiation was performed culturing PDL5-
F3 cells in AM for 21 days, and confirmed by Oil Red O
staining of the multiple intracellular lipid-filled droplets ac-
cumulation and microscopic observations in brightfield con-
trol (Figure 4). 
The same behavior, using OM or AM, was confirmed in the
CD44+ PDL population, before cell cloning (data not shown).
Proliferation process of PDL5-F3 cells in presence of dif-
ferent concentrations of SrCl2
We have evaluated the effects of different concentrations of
SrCl2 (0.5 -1 -5 -10 -25 -50 -100 -250 -500 μg/ml) on the pro-
liferation process of human PDL5-F3 cells. 
Figure 5 shows a significant increase in the incorporation of
[3H]-thymidine when PDL5-F3 cells were treated for 24 hours
with SrCl2 at concentrations from 25 to 500 μg/ml, with re-
spect to the control group in Coon’s modification medium
with 0.1% FBS (with p≤0.05). In particular, this increase in
proliferation rate was highest in PDL5-F3 cells stimulated
with 100 μg/ml SrCl2 (+37.7%) and lowest when PDL5-F3
cells were treated with 25 μg/ml SrCl2 (+14.9%). On the con-
trary, lower concentrations of SrCl2, from 0.5 to 10 μg/ml, did
not have any effect on the proliferation process, given that
we did not detect any increment of [3H]-thymidine incorpora-
tion with respect to the control 0.1% FBS.
Cell cultures, analyzed during proliferation in the presence of
various concentrations of SrCl2 for 24 hours and assessed
by MTT assay, have shown a viability higher than 96% (data
not shown) (Figure 5).
Mineralization process of PDL5-F3 in presence of differ-
ent concentrations of SrCl2
In order to evaluate the effect of SrCl2 on the mineralization
process of PDL5-F3 cells, osteogenic differentiation media
with concentrations of SrCl2 from 0.5 to 500 μg/ml were used
and refreshed twice a week, for the entire study period (28
days).
Not surprisingly, the calcium content increased in a time-de-
pendent manner in PDL5-F3 cultivated in OM, without SrCl2,
used as positive control (Figure 6).
Figure 6 shows that concentrations of SrCl2 lower than 25
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Figure 2 - Phenotype characterization of PDL5-F3 cells by flow cytometry. The overly plots show the percentage of PDL5-F3 cells expressing the sur-
face markers CD45, CD105, CD90, CD44, CD34, CD133, CD117 and CD271 (open histograms); grey histograms: autofluorescence of unstained cells.
One experiment representative of three independent ones.
CCMBM 1 2017-3bOK.qxp_-  18/12/17  14:59  Pagina 287
μg/ml have caused significant increases in the production of
mineralized calcium nodules already observed after 14 days
of osteogenic induction and reached a maximum at 28 days,
compared to the not induced control. In particular, 28 days
after induction, the minimum percentage increase of calcium
deposits is valued at 10 μg/ml SrCl2 (+71.6%) and the maxi-
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Figure 3 - Osteogenic phenotype evaluation of the
PDL5-F3 cell line. a, b, c, d are representative im-
ages of Fast Red Violet BB staining at time 0 and
after 4, 7 and 14 days of osteogenic induction;
ALP+ cells are in red and nuclei counterstained
with Mayer’s acid hemalum in blue. Images ac-
quired in brightfield microscopy. Objective 40x. e,
f, g, h are representative images of calcein stain-
ing at time 0 and after 7, 14 and 21 days of os-
teogenic induction; mineralized calcium deposits
are in fluorescent green and nuclei counterstained
with propidium iodide in conventional red color.
Images acquired in epifluorescence microscopy.
Objective 40x.
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mum at 0.5 μg/ml SrCl2 (+153.5%). Concentrations of 25 and
50 μg/ml did not produce any significant increment of calci-
um deposition with respect to the osteogenic positive control
during the entire study period. Otherwise, SrCl2 concentra-
tions of 100, 250 and 500 μg/ml affected mineralization after
28 days of osteoinduction, leading to a decrease in calcium
deposits respectively of 29.8, 35 and 28%, compared to the
osteogenic control.
Quantitative data reporting mineralization and Ca2+ deposi-
tion of PDLSCs, after 28 days of osteoinduction in presence
of SrCl2 treatments, were supported by epifluorescence mi-
croscopy observations (Figure 7). As shown in Figure 7,
Ca2+ mineral deposits were increased, respect to the control
group, in samples treated with SrCl2 concentrations from 0.5
to 10 μg/ml; not differences were microscopically detected in
samples treated with SrCl2 25 and 50 μg/ml, whereas in
samples treated with concentrations from 100 to 500 μg/ml,
consistent decrements in Ca2+ nodules were observed.
Discussion
Numerous studies have demonstrated that the human PDL
contains a population of multipotent postnatal stem cells that
can be expanded ex vivo, providing a unique reservoir of
stem cells to be used for periodontal therapy (1, 13). Indeed,
they have shown that PDL has a good potential of promoting
regeneration of cementum and PDL-like tissues, as reported
in in vivo animal models and in human case reports (1, 14-
16). According to these findings, we have focused our study
on supporting the efficacy of utilizing autologous PDL cells in
the treatment of human periodontitis.
In our study, we successfully isolated PDLSCs from a human
third molar, extracted for orthodontic purpose. Positive selec-
tion with CD44, transmembrane glycoprotein and marker of
mesenchymal stemness, has permitted us to obtain and iso-
late putative stem cells that were highly enriched for this par-
ticular subset, which were used in our experiments (17, 18).
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Figure 4 - Adipogenic phenotype evaluation of
the PDL5-F3 cell line. Representative images of
Oil Red O staining at time 0 (a) and after 21 days
(b) of adipogenic induction; the intracellular
droplets of lipids are in red, and nuclei counter-
stained with Mayer’s acid hemalum in blue. Im-
ages acquired in brightfield microscopy. Objec-
tive 40x.
Figure 5 - [3H]-thymidine incorporation in PDL5-F3 cell line assessed after 24h in presence of different concentrations of SrCl2 (from 0.5
to 500 μg/ml)
.  
The values are the median of six independent experiments. Significance was obtained by Kruskal-Wallis Test, compar-
ing the value of [3H]-thymidine incorporation in presence of different SrCl2 concentrations with respect to control without stimuli (FBS
0.1%). Radioactivity was expressed as disintegration per minute (DPM)/well. *p≤0.05 vs control. Whiskers represent a non-parametric
95% confidence interval.
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Moreover, we have purposely chosen CD44 membrane
marker for selecting PDLSCs because of this protein is
largely known to be crucial for the proliferation and mineral-
ization of PDL cells and may play multiple important roles in
the biological function of periodontal regeneration (19, 20).
Afterwards, we have established a CD44+ PDL clonal cell
line, since this has permitted us to analyze a more homoge-
neous population and obtain experimental reproducibility,
with the final aim to clarify the PDL-regenerative mechanism
(21, 22).
The FACS analysis has assessed not only the mesenchymal
origin but also the non-malignancy of our clone. In particular,
the negative results obtained analyzing the main surface
markers expressed within the majority of solid tumors
(CD133, CD117, CD34 and CD271) (23-27), together with
the cell inability to form colonies in soft agar (28), confirmed
that no malignant transformation occurred during cloning of
PDL cells. 
In order to assess its potential and capability to differentiate
into different lineages, we induced the clonal CD44+ PDL
line toward adipogenic and osteogenic phenotypes. Both of
the phenotypes were verified, confirming the efficacy of the
selected clone for further experiments.
Advanced research has involved the combination of
PDLSCs with growth factors such as BMP-2 (29), PDGF,
IGF-1 (30-32) but also FGF-2 and VEGF-A (33) with the final
aim to support the PDL tissue regeneration process.
In this study, we have focused our attention on strontium, an
alkaline earth metal, since it promotes bone formation and
decreases bone reabsorption. It has been reported that
strontium preferentially stimulates cell proliferation of mes-
enchymal and osteoblastic cells (10, 34) and, because of the
osteoblast-like characteristics of the PDL cells, we may con-
sider it an elective factor to be used in PDL regenerative
therapy. 
Literature reports the effects of strontium in PDL regenera-
tion, demonstrating its ability to promote proliferation and os-
teogenic differentiation of PDLSCs (11, 12, 35, 36), but in
these studies they have tested few and different concentra-
tions of strontium and examined only a single process at
once.
Therefore, our purpose was to assess whether and in which
way the same concentrations of SrCl2 (from 0.5 to 500
μg/ml) may influence both of the proliferation activity and the
mineralization process of PDLSCs. It is desirable indeed, in
order to assume the effective use of strontium in the PDL re-
generation, to have a full knowledge of the effects that this
bioactive ion may induce on PDLSCs, identifying the most
active concentrations for proliferation and differentiation.
The obtained results showed that only the higher tested con-
centrations of strontium (from 25 μg/ml to 500 μg/ml) can
significantly affect the proliferation activity of PDLSCs,
demonstrating a fast proliferative response during the first 24
hours of treatments with SrCl2. On the contrary, when we as-
sayed the mineralization activity of PDLSCs in the presence
of the entire range of strontium concentrations, we found that
the ion induced a biphasic effect on this process. Specifical-
ly, with respect to the control group without treatments, low
strontium concentrations, from 0.5 to 10 μg/ml, had stimula-
tory effects on calcium nodule deposition, whereas interme-
diate concentrations, from 25 to 50 μg/ml, induced no signifi-
cant effects on mineralization. Higher concentrations, from
100 to 500 μg/ml, inhibit the deposition of mineralized nod-
ules at 28 days after induction, probably due to the fact that
these concentrations of strontium may disturb mineralization,
interfering with the hydroxyapatite formation and physico-
Clinical Cases in Mineral and Bone Metabolism 2017; 14(3):283-293290
C. Romagnoli et al.
Figure 6 - Quantitative analysis of mineralized calcium deposits in PDL5-F3 induced in presence of different concentrations of SrCl2,
from 0.5 to 500 μg/ml, up to 35 days. The values are the median of six independent experiments. The significance was evaluated by
Kruskal-Wallis Test, comparing the value of calcium deposits in presence of different Sr2+ concentrations at different experimental
points with respect to control group without stimuli. *p≤0.05 vs OM control at the same time; §p≤0.01 vs OM control at the same time.
Whiskers represent a non-parametric 95% confidence interval.
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Figure 7 - Representative images of mineralized calcium
deposits after 28 days of osteoinduction in absence of Sr-
Cl2 (OM) or in presence of different concentrations of the
ion: control (a); 0.5 μg/ml (b); 1 μg/ml (c); 5 μg/ml (d); 10
μg/ml (e); 25 μg/ml (f); 50 μg/ml (g); 100 μg/ml (h); 250
μg/ml (i); 500 μg/ml (l). Mineralized calcium deposits,
stained with calcein, are in fluorescent green and nuclei,
counterstained with propidium iodide, in conventional red
color. Images acquired in epifluorescence microscopy. Ob-
jective 10x.
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chemical crystal properties (37, 38). 
Our finding agree with previous data obtained by our re-
search group, according to which strontium can distinctly in-
duce proliferation or mineralization activity on human adi-
pose tissue-derived mesenchymal stem cells, according to
the used high or low concentrations (10). 
Altogether, our results have provided evidence that the wide
range of tested SrCl2 concentrations can promote on
PDLSCs either the one or the other process at different time
points, underlining the complexity of the mechanism of ac-
tions of the ion, which, to date, is still unknown and subject
to further investigation.
Indeed, it has been demonstrated in vitro in osteoblasts that
strontium promotes extracellular-signal regulated kinase
(ERK) phosphorilation via the calcium sensing receptor
(CaSR), which in turn improves cell replications (39). This in-
teraction with CaSR also resulted in activation of inositol
triphosphate production and mitogen-activated protein ki-
nase signaling and induction of cyclooxygenase-2 expres-
sion, which brought to an increase of prostaglandin-E2 pro-
duction (40-42). Furthermore, other mechanisms are also
thought to be involved in regulation or mediation of mes-
enchymal and osteoblast cell replication via protein kinase
C/D and p38 signaling pathways (43, 44). Recently, it was
shown that the Wnt signaling pathway was involved in stron-
tium-induced proliferation and differentiation of the murine
osteoblasts (45). Moreover, it was found that strontium could
enhance the osteogenic differentiation of mesenchymal stem
cells, with upregulated extracellular matrix gene expression
and activated Wnt/β catenin pathway (9).
Despite the remaining questions regarding mechanism of ac-
tion, our study demonstrates the importance of strontium on
PDL proliferation/osteogenesis and confirms it as a promis-
ing bioactive factor in PDL regeneration. We have shown ev-
idence of the proliferative and mineralization effects in stron-
tium-exposed PDLSCs, but concentrations to obtain the spe-
cific event are opposite. Both observed phenomena offer de-
sirable conditions for guided periodontal regeneration and
might help to improve the outcome of periodontal regenera-
tion therapy. In fact, incorporation of strontium into a delivery
system that can release, with a control release profile over
time, the appropriate concentration, chosen according to the
specific biological response of PDLSCs that we want, might
represent a possibility for developing innovative strategies
capable not only of improving proliferation but also of in-
creasing new bone formation. Thus, it is plausible that the
use of strontium may become an elective treatment in many
future options for a large variety of dental applications. Addi-
tional clinical studies are required to fully characterize the
possible beneficial effects of strontium in vivo.
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